Mastering Protein Aggregation: Unveiling Analytical Insights, Strategies, and Innovation in Biopharmaceuticals
The "Particles and Protein Aggregation in Parenteral Products Masterclass" delves into the multifaceted world of protein aggregation in biopharmaceuticals. This comprehensive course, structured over three detailed half-days, is an exploration into both the theoretical and practical aspects of protein aggregation. Participants will be introduced to a variety of protein aggregates, their formation mechanisms, and the critical impact they have on drug development and patient safety. The training emphasizes the importance of understanding these aggregates in the context of therapeutic protein products.
The course introduces participants to advanced analytical methods, including novel techniques developed by Therapeomic. These methods are crucial for the detailed physicochemical analysis of pharmaceuticals, aiding in the identification and characterization of protein aggregates. The curriculum is further enriched with discussions on high throughput analysis and formulation, equipping attendees with the necessary tools for effective protein formulation development. Throughout the training, participants will engage in interactive sessions, case studies, and practical workshops, providing a well-rounded educational experience that is both intellectually stimulating and professionally beneficial
Participants will also be able to delve into mitigation strategies and formulation development, offering practical insights into preventing and controlling protein aggregation. This includes a focus on formulation design principles, compatibility studies, and regulatory guidelines, equipping attendees with the tools they need to navigate the complex landscape of parenteral product development. Under the expert guidance of Prof. Dr. Tudor Arvinte, this course promises to be an enlightening and essential experience for professionals in the biopharmaceutical industry.
.webp)
Cutting-Edge Analytical Techniques: Exploration of modern methods like fluorescence spectroscopy for precise protein aggregate analysis.
Understanding Aggregation Dynamics: Detailed examination of the causes and development of protein aggregates in parenteral products.
Evaluating Aggregate Impact: Analysis of how aggregates affect the quality, safety, and therapeutic efficacy of biopharmaceuticals.
Strategies for Aggregate Reduction: Focus on innovative approaches to minimize protein aggregation during product development.
Regulatory Aspects on Protein Aggregates: Understand the regulatory guidelines and compliance requirements for therapeutic protein products.
Case Studies and Practical Workshops: Interactive sessions providing real-life examples and hands-on experience in tackling aggregation challenges
WHY JOIN THE EVENT
Advanced Analytical Techniques: Gain proficiency in cutting-edge methods such as fluorescence spectroscopy and electron microscopy for detecting and characterizing protein aggregates
Mechanisms of Protein Aggregation: Understand the underlying processes that lead to protein aggregation, crucial for ensuring drug stability and efficacy
Impact Assessment: Evaluate the effects of protein aggregation on drug safety, efficacy, and immunogenicity, providing a comprehensive understanding of the challenges
Mitigation Strategies: Develop strategies for preventing and controlling protein aggregation, focusing on effective formulation design and problem-solving
Regulatory Compliance: Learn from case studies about regulatory guidelines and compliance requirements regarding aggregation in therapeutic protein products
Practical Application: Apply the theoretical knowledge in real-world scenarios, enhancing skills in formulation development and quality assurance in biopharmaceuticals
WHO SHOULD ATTEND
Protein Formulation and Structure Specialists
.png)
QA/QC Scientists
Product Stability Managers
Biotherapeutics Analytical Scientists
CMC Heads, Lead Analysts
THE CURRICULUM
Engage in meaningful discussions, share insights, and build valuable connections within your industry. Our masterclasses provide a platform to expand your professional network.
Immerse yourself in the latest industry trends and innovations. Our masterclasses feature thought leaders who will share their expertise, providing you with valuable knowledge and perspectives.
Have burning questions or seek clarification? Take advantage of interactive Q&A sessions with our distinguished trainers. Get direct insights and deepen your understanding of key topics.
Attendees gain exclusive access to event-related materials, ensuring you stay informed even after the event concludes. Dive deeper into the subject matter with resources curated for your professional growth.
THE SPEAKERS
Tudor Arvinte, Ph.D., received his academic training in physics at the University of Jassy, Romania, and his Ph.D. in biophysics from the University of Düsseldorf, Germany. He performed his doctoral work and postdoctoral stage at the Max-Planck-Institute West Germany and held numerous research positions in Europe and the USA: at C.N.R.S., Orléans, France, at Cornell University, New York, at Texas A&M University, and at the Biophor Corporation, College Station, Texas, USA. In 1989 he joined Ciba-Geigy Pharmaceuticals in Horsham, England, and in 1994 he moved to Ciba-Geigy in Basel, Switzerland (Novartis since 1997). Until 2002 he worked as Head of Exploratory Formulation, Novartis Biotechnology Development & Production, Basel. T. Arvinte worked on the characterization and formulation of more than 200 protein and peptide drugs. Four of his protein formulations reached the market: the formulations were developed using High Throughput Analytic (HTA) and High Throughput Formulation (HTF) methods developed by T Arvinte. T. Arvinte has 90 publications, 12 book chapters, holds 15 patents on formulations of proteins, and gave more than 490 invited lectures at scientific meetings, regulatory bodies, and pharmaceutical companies. T. Arvinte was Titular Professor at the School of Pharmacy, University of Geneva, Switzerland where he is teaching a post-graduate course on “Formulation and delivery of protein biopharmaceuticals” until 2023. He co-founded Therapeomic, Inc., a biotech company focused on developing formulations for biopharmaceuticals in collaborations with pharmaceutical companies.
Prof. Dr. Tudor Arvinte
Titular Professor of Biopharmaceutics, School of Pharmaceutical Sciences and University of Geneva CEO of Therapeomic Inc
Trusted by Industry Leaders: Join the Ranks of Top Companies Partnering with Learnova for Excellence in Training and Development.
SIGN UP
Submit your details to receive the detailed agenda. And can you reduce the size of this overall section.
Learnova specializes in industry-specific masterclasses covering sectors such as Banking, Healthcare, Energy, Human Resources, and more. Our courses aredesigned to provide practical and up-to-date knowledge led by industry experts.
Our trainings are conducted by industry thought leaders and experts with extensive experience in their respective fields. You'll learn from professionals who bring real-world insights to the learning environment.
Learnova offers the flexibility of both online and in-person trainings. Choose the format that best suits your preferences and schedule. Our virtual sessions are designed to be as interactive and engaging as our physical classes.
Enrolling in a Learnova training is easy. Simply browse our course catalog, select the desired masterclass, and fill in the form at the bottom of the page. As soon as we receive a request, one of our representatives will get in touch with you to take you through the registration process.
Yes, participants have access to course materials even after completing the masterclass. We believe in providing ongoing resources to support your continued learning and professional development.
Prerequisites vary by course. While some masterclasses may have specific requirements, many are designed to accommodate professionals at various career stages. Check the course details for specific prerequisites or contact our team for personalized guidance.
There is a registration fee associated with enrollment, which contributes to the development of expert-led content, interactive learning experiences, and ongoing support. Please check the specific course details for pricing information or contact our team for assistance with any payment-related queries.
Yes, Learnova values group learning experiences. We offer attractive group discounts for corporate teams and organizations enrolling multiple participants in our masterclasses.
Yes, upon successfully completing a masterclass,you will be awarded a certificate of completion. This certificate serves as a recognitionof your commitment to professional development and mastery in your chosenfield.
